Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett’s Esophagus

Stuart J. Thomas, Lucy Almers, Jennifer Schneider, James E. Graham, Peter J Havel, Douglas A. Corley

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Abdominal obesity is a risk factor for Barrett’s esophagus independent of GERD symptoms, but little is understood about the biological mechanisms between obesity and the carcinogenic pathway of esophageal adenocarcinoma. Aims: To evaluate whether ghrelin and leptin may partially explain the association between obesity and Barrett’s esophagus. Methods: We conducted a case–control study using patients with a new diagnosis of Barrett’s esophagus (cases) and two control groups frequency matched to cases for age, gender, and geographic region: (1) patients with gastroesophageal reflux disease (GERD) and (2) a sample of the general population. We generated odds ratios using logistic regressions to evaluate quartiles of serum ghrelin or serum leptin, adjusting for known risk factors for Barrett’s esophagus. We evaluated potential interaction variables using cross products and ran stratified analyses to generate stratum-specific odds ratios. Results: A total of 886 participants were included in the analysis. Higher ghrelin concentrations were associated with an increased risk of Barrett’s esophagus, when compared to the population controls, but not the GERD controls. Ghrelin concentrations were not associated with the frequency of GERD symptoms, but ghrelin’s relationship with Barrett’s esophagus varied significantly with the frequency of GERD symptoms. Leptin concentrations were positively associated with at least weekly GERD symptoms among the population controls and were inversely associated with Barrett’s esophagus only among the GERD controls. Adjusting for waist circumference did not change the main associations. Conclusion: Higher levels of ghrelin were associated with an increased risk of Barrett’s esophagus among the general population. In contrast, leptin was positively associated with frequent GERD symptoms, but inversely associated with the risk of Barrett’s esophagus among the GERD controls.

Original languageEnglish (US)
Pages (from-to)70-79
Number of pages10
JournalDigestive Diseases and Sciences
Volume61
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Ghrelin
Barrett Esophagus
Gastroesophageal Reflux
Leptin
Population Control
Obesity
Odds Ratio
Abdominal Obesity
Waist Circumference
Serum
Population
Adenocarcinoma
Logistic Models
Control Groups

Keywords

  • Barrett’s esophagus
  • GERD
  • Ghrelin
  • Leptin
  • Obesity

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett’s Esophagus. / Thomas, Stuart J.; Almers, Lucy; Schneider, Jennifer; Graham, James E.; Havel, Peter J; Corley, Douglas A.

In: Digestive Diseases and Sciences, Vol. 61, No. 1, 01.01.2016, p. 70-79.

Research output: Contribution to journalArticle

Thomas, Stuart J. ; Almers, Lucy ; Schneider, Jennifer ; Graham, James E. ; Havel, Peter J ; Corley, Douglas A. / Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett’s Esophagus. In: Digestive Diseases and Sciences. 2016 ; Vol. 61, No. 1. pp. 70-79.
@article{db979fb79e6e4c79856a4793d4516533,
title = "Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett’s Esophagus",
abstract = "Background: Abdominal obesity is a risk factor for Barrett’s esophagus independent of GERD symptoms, but little is understood about the biological mechanisms between obesity and the carcinogenic pathway of esophageal adenocarcinoma. Aims: To evaluate whether ghrelin and leptin may partially explain the association between obesity and Barrett’s esophagus. Methods: We conducted a case–control study using patients with a new diagnosis of Barrett’s esophagus (cases) and two control groups frequency matched to cases for age, gender, and geographic region: (1) patients with gastroesophageal reflux disease (GERD) and (2) a sample of the general population. We generated odds ratios using logistic regressions to evaluate quartiles of serum ghrelin or serum leptin, adjusting for known risk factors for Barrett’s esophagus. We evaluated potential interaction variables using cross products and ran stratified analyses to generate stratum-specific odds ratios. Results: A total of 886 participants were included in the analysis. Higher ghrelin concentrations were associated with an increased risk of Barrett’s esophagus, when compared to the population controls, but not the GERD controls. Ghrelin concentrations were not associated with the frequency of GERD symptoms, but ghrelin’s relationship with Barrett’s esophagus varied significantly with the frequency of GERD symptoms. Leptin concentrations were positively associated with at least weekly GERD symptoms among the population controls and were inversely associated with Barrett’s esophagus only among the GERD controls. Adjusting for waist circumference did not change the main associations. Conclusion: Higher levels of ghrelin were associated with an increased risk of Barrett’s esophagus among the general population. In contrast, leptin was positively associated with frequent GERD symptoms, but inversely associated with the risk of Barrett’s esophagus among the GERD controls.",
keywords = "Barrett’s esophagus, GERD, Ghrelin, Leptin, Obesity",
author = "Thomas, {Stuart J.} and Lucy Almers and Jennifer Schneider and Graham, {James E.} and Havel, {Peter J} and Corley, {Douglas A.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/s10620-015-3867-6",
language = "English (US)",
volume = "61",
pages = "70--79",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett’s Esophagus

AU - Thomas, Stuart J.

AU - Almers, Lucy

AU - Schneider, Jennifer

AU - Graham, James E.

AU - Havel, Peter J

AU - Corley, Douglas A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background: Abdominal obesity is a risk factor for Barrett’s esophagus independent of GERD symptoms, but little is understood about the biological mechanisms between obesity and the carcinogenic pathway of esophageal adenocarcinoma. Aims: To evaluate whether ghrelin and leptin may partially explain the association between obesity and Barrett’s esophagus. Methods: We conducted a case–control study using patients with a new diagnosis of Barrett’s esophagus (cases) and two control groups frequency matched to cases for age, gender, and geographic region: (1) patients with gastroesophageal reflux disease (GERD) and (2) a sample of the general population. We generated odds ratios using logistic regressions to evaluate quartiles of serum ghrelin or serum leptin, adjusting for known risk factors for Barrett’s esophagus. We evaluated potential interaction variables using cross products and ran stratified analyses to generate stratum-specific odds ratios. Results: A total of 886 participants were included in the analysis. Higher ghrelin concentrations were associated with an increased risk of Barrett’s esophagus, when compared to the population controls, but not the GERD controls. Ghrelin concentrations were not associated with the frequency of GERD symptoms, but ghrelin’s relationship with Barrett’s esophagus varied significantly with the frequency of GERD symptoms. Leptin concentrations were positively associated with at least weekly GERD symptoms among the population controls and were inversely associated with Barrett’s esophagus only among the GERD controls. Adjusting for waist circumference did not change the main associations. Conclusion: Higher levels of ghrelin were associated with an increased risk of Barrett’s esophagus among the general population. In contrast, leptin was positively associated with frequent GERD symptoms, but inversely associated with the risk of Barrett’s esophagus among the GERD controls.

AB - Background: Abdominal obesity is a risk factor for Barrett’s esophagus independent of GERD symptoms, but little is understood about the biological mechanisms between obesity and the carcinogenic pathway of esophageal adenocarcinoma. Aims: To evaluate whether ghrelin and leptin may partially explain the association between obesity and Barrett’s esophagus. Methods: We conducted a case–control study using patients with a new diagnosis of Barrett’s esophagus (cases) and two control groups frequency matched to cases for age, gender, and geographic region: (1) patients with gastroesophageal reflux disease (GERD) and (2) a sample of the general population. We generated odds ratios using logistic regressions to evaluate quartiles of serum ghrelin or serum leptin, adjusting for known risk factors for Barrett’s esophagus. We evaluated potential interaction variables using cross products and ran stratified analyses to generate stratum-specific odds ratios. Results: A total of 886 participants were included in the analysis. Higher ghrelin concentrations were associated with an increased risk of Barrett’s esophagus, when compared to the population controls, but not the GERD controls. Ghrelin concentrations were not associated with the frequency of GERD symptoms, but ghrelin’s relationship with Barrett’s esophagus varied significantly with the frequency of GERD symptoms. Leptin concentrations were positively associated with at least weekly GERD symptoms among the population controls and were inversely associated with Barrett’s esophagus only among the GERD controls. Adjusting for waist circumference did not change the main associations. Conclusion: Higher levels of ghrelin were associated with an increased risk of Barrett’s esophagus among the general population. In contrast, leptin was positively associated with frequent GERD symptoms, but inversely associated with the risk of Barrett’s esophagus among the GERD controls.

KW - Barrett’s esophagus

KW - GERD

KW - Ghrelin

KW - Leptin

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84952984319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952984319&partnerID=8YFLogxK

U2 - 10.1007/s10620-015-3867-6

DO - 10.1007/s10620-015-3867-6

M3 - Article

C2 - 26396004

AN - SCOPUS:84952984319

VL - 61

SP - 70

EP - 79

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 1

ER -